143 related articles for article (PubMed ID: 10897207)
1. [Reevaluation of immunopotentiation therapy for cancer].
Toyoshima K
Gan To Kagaku Ryoho; 2000 Jun; 27(6):817-23. PubMed ID: 10897207
[TBL] [Abstract][Full Text] [Related]
2. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
3. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
4. [BCG vaccine immunotherapy after radical operations for lung cancer].
Repin IuM
Vestn Khir Im I I Grek; 1992; 149(7-8):11-6. PubMed ID: 1341347
[TBL] [Abstract][Full Text] [Related]
5. Patient-recognition data-mining model for BCG-plus interferon immunotherapy bladder cancer treatment.
Shah SC; Kusiak A; O'Donnell MA
Comput Biol Med; 2006 Jun; 36(6):634-55. PubMed ID: 15978568
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for colo-rectal cancer.
Wilson RE
Ann Chir Gynaecol; 1983; 72(6):290-2. PubMed ID: 6364949
[No Abstract] [Full Text] [Related]
8. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy of lung cancer].
Jassem J; Jassem E
Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
[No Abstract] [Full Text] [Related]
10. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of carcinoma of the lung].
Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
[No Abstract] [Full Text] [Related]
12. M-Vax: an autologous, hapten-modified vaccine for human cancer.
Berd D
Expert Rev Vaccines; 2004 Oct; 3(5):521-7. PubMed ID: 15485331
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy in superficial bladder carcinoma].
Ríos González E; Martínez-Piñeiro Lorenzo L; Martínez-Piñeiro Caramés JA; de la Peña Barthel JJ
Arch Esp Urol; 2000 Dec; 53(10):879-92. PubMed ID: 11213392
[TBL] [Abstract][Full Text] [Related]
14. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant BCG therapy in radical resection of lung cancer].
von Schlieben I; Calavrezos A; Koschel G; Seysen U
Prax Klin Pneumol; 1984 Mar; 38(3):102-3. PubMed ID: 6371772
[No Abstract] [Full Text] [Related]
16. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy with BCG in pulmonary tumors].
Tanzj PL
Minerva Med; 1976 Dec; 67(63):4167-72. PubMed ID: 1018810
[TBL] [Abstract][Full Text] [Related]
18. Current vaccine updates for lung cancer.
Simmons O; Magee M; Nemunaitis J
Expert Rev Vaccines; 2010 Mar; 9(3):323-35. PubMed ID: 20218860
[TBL] [Abstract][Full Text] [Related]
19. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A
BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for prostate cancer - recent progress in clinical trials.
Kipp RT; McNeel DG
Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
